Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$0.68 -0.07 (-9.16%)
At close: Oct 20, 2026 · 4:00 PM EDT

Scinai Immunotherapeutics (SCNI) Cost of Revenue (2024 - 2026)

Updated

Scinai Immunotherapeutics' Cost of Revenue was $1.71 million in Q2 2026, up 1.6% from $1.69 million a year earlier and up 6.5% from the prior quarter.

Analysis

Scinai Immunotherapeutics (SCNI) Cost of Revenue (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Scinai Immunotherapeutics' Cost of Revenue was $5.36 million through Jun 30, 2026, up 89.3% year-over-year; for FY2025, it came in at $6.72 million, up 443.1% from FY2024.

  • In earlier years, Cost of Revenue was $1.24 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 8.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 4.29 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.52 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 4.09 Bn
10 Scinai Immunotherapeutics 157,066.38 -8.11 Mn -1.25 Mn 1.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.71 Mn
Mar 31, 2026 1.61 Mn
Jun 30, 2025 1.69 Mn
Mar 31, 2025 358,000.00
Dec 31, 2024 373,000.00
Sep 30, 2024 417,000.00
API Access

Scinai Immunotherapeutics Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=SCNI&period=max&api_key=YOUR_API_KEY